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Introduction 
Detecting myocardial dysfunction during the 
reperfusion phase after coronary artery bypass 
grafting (CABG) significantly affects patient 
management as it can predict the need for 
inotropic support or assisted devices during 
weaning from cardiopulmonary bypass (CPB) [1, 
2]. Detection of myocardial damage and its degree 
during open heart surgery were studied previously 
using different biomarkers such as creatine kinase 
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Abstract 
Background: Detection of myocardial damage and its degree during open heart 
surgery were studied previously using different biomarkers. Heart fatty acid 
binding protein (h-FABP) was used in the diagnosis of myocardial infarction with 
variable results. In this study, we aimed to find the possibility of the use of this 
biomarker as a predictor of myocardial damage after coronary artery bypass graft 
(CABG) surgery. 
Methods: We conducted a prospective study on 47 patients who had CABG 
surgery. Blood samples (4 ml) were drawn from patients at 5 points: before 
induction of anesthesia, after aortic declamping, 1 hour after declamping, 6 hours 
after declamping and one day after surgery. Levels of h-FABP and creatine kinase 
muscle/brain (CK-MB) were estimated, and the relationship between h-FABP and 
operative and postoperative outcomes were recorded.  
Results: There were statistically significant correlations between higher levels of h-
FABP measured immediately after aortic declamping and need for intra-aortic 
balloon (116.55 + 9.26 vs, 84.34 + 19.55 ng/ml; p= 0.022), inotropes (107.04+ 14.79 
vs, 79.95 + 17.59ng/ml; p< 0.001), defibrillators (97.73 + 15.18 vs 81.59 + 20.31 
ng/ml; p=0.016), and postoperative atrial fibrillation (99.94 + 17.83 vs 80.84 + 
18.89ng/ml; p= 0.004). No mortality was detected in our study. h-FABP levels 
showed an early peak just after aortic declamping and reached baseline by 
postoperative day one. CK-MB peaked 1 hour after aortic declamping and 
remained elevated for more than 24 hours. 
Conclusion: h-FABP is a cardiac biomarker that could be used as a rapid indicator 
of ventricular dysfunction and atrial fibrillation post-CABG surgery. 
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muscle/brain (CK-MB) and troponin I. However, 
these biomarkers peak several hours after surgery 
and return to normal values several days after the 
operation which limits their role after cardiac 
surgery [3]. 
Heart fatty acid binding protein (h-FABP) is a 
small hydrophilic protein found in cardiomyocytes 
that leaks rapidly after myocardial damage with 
early clearance from circulation [4]. Heart fatty 
acid binding protein was used in the diagnosis of 
myocardial infarction and myocardial injury with 
variable results [5]. Currently, the role of h-FABP 
in cardiac surgery is limited; however; it emerged 
as a potential outcome predictor for cardiac 
disease and after surgery [6]. 
In this study, we aimed to find the relation 
between h-FABP levels and the degree of 
myocardial damage after CABG surgery by 
studying its correlation with different outcomes. 
Additionally, we evaluated the possibility of using 
this biomarker as a predictor of ventricular 
dysfunction after CABG. 
Patients and Methods: 
Design and Patients:  
This study was a prospective cohort study 
conducted on 47 patients who had CABG during 
six months period from January 2018 till June 
2018. Patients who had an emergency, redo 
surgery, and those with combined valve and CABG 
surgery were excluded. Informed consent was 
taken from all patients, and the local Ethical 
Committee approved it.  
Data and technique:  
All patients enrolled in the study were 
subjected to complete examination, including full 
history taking, routine laboratory investigations, 
preoperative electrocardiography (ECG), 
echocardiography, and coronary angiography. All 
vessels showing more than 70% stenosis were 
bypassed.  
All patients were subjected to standard 
median sternotomy, cardiopulmonary bypass via 
direct aortic cannulation and right atrial 
cannulation. Antegrade crystalloid cardioplegia 
was given, and surgery was done under 
hypothermic cardiac arrest. Left internal 
mammary artery (LIMA) was harvested to bypass 
left anterior descending (LAD) artery, and 
saphenous vein grafts were used to bypass other 
vessels. All distal anastomoses were done under 
complete cardiac arrest, and proximal 
anastomoses were done using partial aortic cross-
clamp. After removal of the aortic clamp, an 
electrical defibrillator was used if there was 
ventricular fibrillation [7]. 
After adequate hemostasis, the chest was 
closed in a routine manner, and patients were 
transferred into the intensive care unit (ICU). 
Postoperative complications including prolonged 
mechanical ventilation, renal dysfunction defined 
as doubling of preoperative creatinine level 
[8], need for inotropes, neurological insults, and 
atrial fibrillation (AF) were recorded.  
Cardiac biomarkers assay:  
Blood samples (4 ml) were drawn from 
patients at 5 points: before induction of 
anesthesia, after removal of the aortic clamp, one 
hour after declamping, 6 hours after declamping, 
one day after surgery. Blood samples were 
collected in a Becton Dickinson BD® vacutainer 
serum separator tube. The separated serum 
samples after centrifugation were divided into two 
portions. The first portion was collected for 
assessment of creatine kinase muscle/brain (CK-
MB) activity. The second portion was collected 
and stored at -70 °C until h-FABP levels were 
assessed. The serum levels of h-FABP were 
measured by enzyme-linked immunosorbent 
assay kits, according to the manufacturer’s 
instructions (Shanghai Sun red Biological 
Technology®, China), using Awareness 
Technology® (USA) ELISA Reader. h-FABP 
concentration was expressed in ng/ml.  
CK-MB activity was determined by immune-
inhibition UV method, according to the 
manufacturer’s instructions (BioSystems®, Spain), 
using Shimadzu® (Japan) Spectrophotometer. CK-
MB activity was expressed in U/L. Relations 
between levels of h-FABP and postoperative 
outcomes were assessed. Additionally, the 
relationship between CK-MB and h-FABP levels 
was studied.  
Statistical analysis: 
Statistical analysis was performed using SPSS 
(statistical package for social sciences) version 23 
(SPSS, Chicago, IL, USA). Data were expressed as 
numbers and frequencies for categorical variables 
and mean+ standard deviation (SD) or median and 
range for continuous variables. 
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Table 1: Patients characters, operative and postoperative data. (Continuous variables are presented as mean± SD and 
categorical variables as number and percent) 
N= 47 
Age (years, mean ± SD) 57.45 + 8.28 
Sex (Male) 32 (68.1%) 
Diabetes mellitus 19 (40.4%) 
Hypertension 26 (55.3%) 
History of myocardial infarction 6 (12.8%) 
Preoperative ejection fraction (%, mean ±SD) 53.49 + 6.14 
Pre-renal dysfunction 2 (4.3%) 
Number of anastomosis [median (range)] 3 (1-4) 
Cardiopulmonary bypass time [min, median (range)] 90 (50-160) 
Aortic cross clamp time (min, mean ± SD) 62.34 + 16.08 
Need for intra-aortic balloon 2 (4.3%) 
Need for defibrillator 12 (25.5%) 
Need for >2 inotropes in ICU 10 (21.3%) 
Duration of mechanical ventilation [hours, median (range)] 6 (3-72) 
Postoperative atrial fibrillation 12 (25.5%) 
Postoperative renal dysfunction 4 (8.5%) 
ICU: Intensive care unit 
Continuous variables were compared using 
student's t-test. For non-parametric data, Mann-
Whitney U test was used instead. Correlations 
between serum levels of h-FABP and preoperative, 
operative, and postoperative data were 
performed using Pearson's correlation coefficient 
for normally distributed data and Spearman' s 
rank correlation coefficient for non-normally 
distributed. P values < 0.05 were considered 
statistically significant. 
Results 
Thirty-two patients were male (68%), and the 
mean age was 57.45+8.28 years. Forty percent of 
patients were diabetic (n=19), and 55% were 
hypertensive (n=26). The number of anastomoses 
used ranged from 1-4 with a median of 3, whereas 
cardiopulmonary bypass (CPB) time ranged from 
50-160 minutes with median of 90 minutes. Cross-
clamp time was 62.34+16.08 minutes. Two 
patients needed an intra-aortic balloon, and ten 
patients needed more than two inotropes as 
indicators of left ventricular dysfunction. Patients' 
characters, operative data, and postoperative 
complications were demonstrated in Table 1. 
Correlations between serum levels of h-FABP 
and preoperative, operative and postoperative 
data are shown in Table 2 - 4. The level of h-FABP 
was not correlated with any of the preoperative 
patients’ characteristics, CPB or ischemic times. 
There were statistically significant correlations 
between higher levels of h-FABP measured 
immediately after aortic declamping and need for 
intra-aortic balloon (116.55 + 9.26 vs, 84.34 + 
19.55 ng/ml; p= 0.022) inotropes (107.04+ 14.79 
vs, 79.95 + 17.59ng/ml; p< 0.001)
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1 hour after 
declamping 




r 0.244 0.34 0.001 0.099 0.017 
P value 0.098a 0.820a 0.995a 0.202a 0.198a 
Sex 
Male 3.32 + 1.02 86.95 + 19.89 77.89+ 19.25 43.77 + 8.22 14.92 + 4.96 
Female 3.43 + 0.86 83.07 + 21.48 71.98 + 18.06 40.97 + 9.47 13.92 + 4.88 
P value 0.678c 0.546c 0.322c 0.307c 0.520c 
Diabetes mellitus 
Yes 3.38 + 1.22 82.42 + 17.19 73.29 + 14.88 42.07 + 8.09 13.71 + 4.21 
No 3.33 + 0.77 87.95 + 22.13 77.85 + 21.24 43.42 + 9.10 15.21 + 5.32 
P value 0.853c 0.364c 0.422c 0.606c 0.310c 
Hypertension 
Yes 3.26 + 0.92 88.72 + 21.13 78.94 + 20.48 44.07 + 8.73 15.46 + 5.12 
No 3.45 + 1.03 81.99 + 18.97 72.37 + 16.47 41.39 + 8.49 13.54 + 4.52 
P value 0.506c 0.262c 0.240c 0.295c 0.184c 
History of myocardial infarction 
Yes 2.95 + 1.08 91.72 + 22.94 79.17 + 18.82 45.13 + 7.63 15.82 + 5.39 
No 3.41 + 0.95 84.84 + 20.00 75.55 + 19.08 42.54 + 8.81 14.42 + 4.88 
P value 0.202d 0.426d 0.630d 0.426d 0.408d 
Pre-renal dysfunction 
Yes 3.05 + 0.78 92.50 + 23.33 81.00 + 15.56 45.85 + 7.57 16.50 + 5.52 
No 3.36 + 0.98 85.41 + 20.36 75.79 + 19.14 42.74 + 8.74 14.52 + 4.93 
P value 0.703d 0.566d 0.599d 0.599d 0.566d 
Pre-operative ejection fraction (%) 
r 0.123 -0.050 -0.032 -0.001 -0.045 
P value 0.409a 0.737a 0.083a 0.413a 0.141a 
* Statistically significant (p < 0.05)
a Pearson correlation coefficient 
c Student's t-test 
d Mann-Whitney U test 
POD: Postoperative day 
 defibrillators (97.73 + 15.18 vs 81.59 + 20.31 
ng/ml; p=0.016) and postoperative atrial 
fibrillation (AF) (99.94 + 17.83 vs 80.84 + 
18.89ng/ml; p= 0.004). No mortality was detected 
in our study.  
The change in levels of h-FABP and CK-MB 
was different as illustrated in Figure 1. h-FABP 
showed early peak just after aortic declamping 
and reached the baseline by postoperative day 
one; whereas, CK-MB peaked 1 hour after aortic 
declamping but did not reach baseline after 24 
hours. 
Discussion 
Early recognition of perioperative myocardial 
damage is essential to prevent complications 
post-CABG surgery [9, 10]. Different biomarkers 
were used for the detection of myocardial 
damage like CK-MB, myoglobin, lactate 
dehydrogenase (LDH), brain natriuretic peptide, 



































































































Figure 1: Difference between hFABP and CK-MB regarding 
rising and falling pattern during and after surgery. 
Each biomarker has its drawbacks, and the 
predictability of each biomarker varies widely in  
clinical practice. h-FABP is a small cardiomyocyte 
protein consisting of 132 amino acid which is 
abundant in the cytoplasm. When myocardial 
damage occurs, it is released into the extracellular 
space, and as a result of its small size, water 
solubility, and physical properties, it enters the 
blood compartment in a rapid manner [12]. In the 
1990s, h-FABP was used in early diagnosis of 
myocardial infarction with different modes of 
release comparable with other markers as it peaks 
early and declines early. However; owing to lack of 
availability and tissue specificity studies, its clinical 
application was limited. The value of h-FABP in 
cardiac surgery was restricted to small studies 
[13]. In our study, we measured h-FABP at 5 
points when samples could be easily drawn 
without interruption to medical staff. We found 
that maximum peak occurred just after removal 
of the aortic clamp and declined earlier than CK-
MB. Petzold and colleagues recommended 
drawing samples when ICU staff having time for 
sophisticated investigations [14].   





1 hour after 
declamping 
6 hours after 
declamping 
POD 1 
Number of anastomoses 
r 0.170 0.033 0.056 0.043 0.309 
P value 0.254b 0.826b 0.708b 0.772b 0.792b 
Cardiopulmonary bypass time (min) 
R 0.141 0.124 0.138 0.135 0.131 
P value 0.586b 0.358b 0.259b 0.394b 0.341b 
Aortic cross-clamp time (min) 
R 0.069 0.190 0.191 0.161 0.179 
P value 0.644a 0.200a 0.199a 0.206a 0.929a 
Need for intra-aortic balloon 
Yes 3.90 + 1.56 116.55 + 9.26 102.55 + 14.92 53.40 + 1.98 22.50 + 2.83 
No 3.32 + 0.95 84.34 + 19.55 74.83 + 18.29 42.41 + 8.53 14.25 + 4.69 
P value 0.535d 0.022*d 0.067*d 0.030*d 0.022*d 
Need for defibrillator 
Yes 3.53 + 1.09 97.73 + 15.18 86.90 + 14.51 48.73 + 4.51 17.62 + 3.67 
No 3.28 + 0.93 81.59 + 20.31 72.27 + 18.93 40.87 + 8.84 13.57 + 4.89 
P value 0.444c 0.016*c 0.019*c 0.005* c 0.012*c 
* Statistically significant (p < 0.05)
a Pearson correlation coefficient 
b Spearman rank correlation coefficient 
c Student's t-test 
d Mann-Whitney U test 
POD: postoperative day 
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1 hour after 
declamping 
6 hours after 
declamping 
POD 1 
Need for > two inotropes in the intensive care unit 
Yes 3.74 + 1.10 107.04+ 14.79 97.20 + 14.31 51.44 + 2.87 20.05 + 3.79 
No 3.24 + 0.91 79.95 + 17.59 70.33 + 15.77 40.56 + 8.21 13.13 + 4.08 
P value 0.148d <0.001*d <0.001*d <0.001*d <0.001*d 
Duration of mechanical ventilation (hours) 
P value 0.319b <0.001*b <0.001*b <0.001*b <0.001*b 
Postoperative atrial fibrillation 
Yes 3.45 + 1.01 99.94 + 17.83 87.05 + 15.38 48.47 + 5.50 17.83 + 4.35 
No 3.31 + 0.96 80.84 + 18.89 72.22 + 18.66 40.96 + 8.74 13.49 + 4.63 
P value 0.672c 0.004*c 0.017*c 0.008*c 0.007*c 
Postoperative renal dysfunction 
Yes 3.2 + 0.98 89.62 + 29.40 77.40 + 27.17 42.75 + 11.67 7.24 + 3.62 
No 3.36 + 0.97 85.35 + 19.66 75.88 + 18.38 42.89 + 8.49 4.75 + 0.72 
P value 0.783d 0.927d 0.840d 0.927d 0.927d 
* statistically significant (p < 0.05)
b Spearman rank correlation coefficient 
c Student's t-test 
d Mann-Whitney U test 
POD= Postoperative day 
Suzuki and associates were the first to 
investigate h-FABP in CABG surgery and reported 
a significant correlation between its value and 
postoperative myocardial damage [15]. Two 
studies later discussed the role of h-FABP as a 
predictor of clinical outcome in pediatric cardiac 
surgery. Evers and colleagues found a weak 
correlation between h-FABP and clinical outcomes 
[16]. However, Hasegawa and colleagues found it 
as a rapid prognostic indicator of myocardial 
damage post pediatric cardiac surgery [17]. 
In our study, we found statistically significant 
correlations between elevated levels of h-FABP 
after aortic declamping and the need for 2 or more 
inotropes post-surgery. This is similar to the study 
carried out by Muehlschlegel and associates. They 
used the requirement for inotropes as an 
indicator of ventricular dysfunction [18]. This 
could explain the increased requirement of 
patients with high levels of h-FABP for intra-aortic 
balloons and defibrillators. By comparing peaks of 
perioperative h-FABP and CK-MB, this study was in 
agreement with Suzuki, Petzold and 
Muehlschlegel and their colleagues. They 
demonstrated that CK-MB peaked 1 hour after 
aortic declamping, making its role limited to the 
prognosis [14, 15, 18]. Therefore, quantitative 
measurement of h-FABP can detect the severity 
of myocardial injury early during cardiac surgery 
[19]. We found no relations between serum 
levels of h-FABP and aortic cross-clamp time and 
cardiopulmonary bypass time. This was in contrast 
to the results reached by Evers and associates who 
found a weak correlation between CPB time and 
h-FABP levels [16]. In the present work, 
postoperative AF was significantly associated with 
increased levels of h-FABP. This was similar to 
Rader and associates who reported a strong 
relation between ischemic myocardial damage 
and postoperative AF [20]. There were no 
statistically significant correlations between 
higher levels of h-FABP and postoperative renal 
dysfunction. This was in contrast to Schaub and 
colleagues who found statistically significant 
associations between plasma levels of h-FABP and 
acute kidney injury following cardiac surgery. 
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Additionally, Kavsak and associates detected 
cutoff points for identification of acute kidney 
injury following cardiac surgery [21, 22]. 
The difference in the predictive value of h-
FABPamong various studies could be attributed to 
the difference in patients’ characteristics and the 
operation performed. However, these studies 
demonstrated the possibility of using h-FABP in 
predicting outcomes after cardiac surgery. This 
biomarker has an advantage over the commonly 
used CK-MB as it tends to peak and decline early. 
Therefore, the change in its level would be 
strongly related to the degree and extent of 
myocardial damage. 
Limitations: 
The limitations of this study are a small number of 
patients included, and the short postoperative 
follow-up period limited to the hospital stay. 
Additionally, this is a single center experience, and 
generalization of the results is an issue. However, 
the study explored the feasibility of using h-FABP 
as a biomarker predicting the hospital outcomes 
after CABG; more extensive studies with longer 
follow up periods are required.  
Conclusion 
h-FABP is a cardiac biomarker that could be 
used as a rapid indicator of ventricular dysfunction 
and atrial fibrillation post-CABG surgery. It could 
be used as a routine marker during cardiac 
surgery. 
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